John Harry Cross III - Chief Financial Officer at Sonnet BioTherapeutics Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
SONN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by John Harry Cross III since 1/8/2024

Holdings reported by John Harry Cross III for Sonnet BioTherapeutics Holdings, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.59K $1.11K $0.70 Dec 11, 2023 Direct

Transactions reported by John Harry Cross III for Sonnet BioTherapeutics Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.